Securian Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,831
Closed -$262K 945
2022
Q4
$262K Hold
5,831
0.01% 868
2022
Q3
$279K Hold
5,831
0.01% 822
2022
Q2
$345K Buy
5,831
+179
+3% +$14.7K 0.01% 834
2022
Q1
$657K Sell
5,652
-100
-2% -$11.7K 0.01% 677
2021
Q4
$866K Buy
5,752
+100
+2% +$13.5K 0.02% 608
2021
Q3
$675K Buy
+5,652
New +$623K 0.01% 663

Other funds holding TNDM

Securian Asset Management's TNDM Position: Q1 2023 in Review

Securian Asset Management sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 5,831 shares — an estimated $262K sold.

Securian Asset Management first reported a position in TNDM in Q3 2021 and held it in 6 quarters. The position peaked at $866K in Q4 2021. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

  • Securian Asset Management reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
  • Securian Asset Management sold 5,831 Tandem Diabetes Care shares in Q1 2023, an estimated $262K.
  • Securian Asset Management first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 6 quarters.
  • Securian Asset Management's Tandem Diabetes Care position peaked at $866K in Q4 2021.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on Securian Asset Management's 13F filing for Q1 2023, filed 27 Apr 2023.